Tonghua Dongbao Pharmaceutical Co (SHSE:600867) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:600867 Tonghua Dongbao Pharmaceutical Co Ltd SHSE:600867
74 GF Score
Price ¥8.51
GF Value ¥10.26
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Tonghua Dongbao Pharmaceutical Co Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

SHSE:600867
74GF Score
Tonghua Dongbao Pharmaceutical Co Ltd SHSE:600867
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Tonghua Dongbao Pharmaceutical Co (SHSE:600867) Overvalued in 2026?

Based on GuruFocus' analysis, Tonghua Dongbao Pharmaceutical Co stock appears to be undervalued. The current stock price of ¥8.51 is trading 17.1% below its estimated GF Value™ of ¥10.26. GuruFocus considers Tonghua Dongbao Pharmaceutical Co to be Modestly Undervalued.

Key valuation signals for SHSE:600867:

  • Dividends Received:
  • GF Value™: ¥10.26 vs. price of ¥8.51 (17.1% below fair value)
  • GF Score™: 74/100 with 6 warning signs

No single metric tells the full story. See the SHSE:600867 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Tonghua Dongbao Pharmaceutical Co Business Description

Address Dongbao Village, Jilin Province, Tonghua, CHN, 134123
Tonghua Dongbao Pharmaceutical Co Ltd is a China-based firm. Its engaged in the production and distribution of pharmaceutical products. Its products include human insulin injection, Heart and brain capsule, Vitamin e soft capsule, and Oral detoxification products.
74GF Score

Get the complete analysis for SHSE:600867

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥8.51
Price
¥10.26
GF Value